Subscribe To Our Free Newsletter |
Sun Pharma: many analysts retain buy rating
Based on average estimated target price, the stock has potential to provide 20% return
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!